摘要
Background: Metformin (MET) is widely used as a first-line hypoglycemic agent for the treatment of type 2 diabetes mellitus (T2DM) and was also confirmed to have a therapeutic effect on type 2 diabetic osteoporosis (T2DOP). However, the potential mechanisms of MET in the treatment of T2DOP are unclear.Objective: To clarify the effect of MET in T2DOP and to explore the potential mechanism of MET in the treatment of T2DOP.Methods: In vitro, we used MC3T3-E1 cells to study the effects of MET on osteogenic differentiation and anti -oxidative stress injury in a high glucose (Glucose 25 mM) environment. In vivo, we directly used db/db mice as a T2DOP model and assessed the osteoprotective effects of MET by Micro CT and histological analysis.Results: In vitro, we found that MET increased ALP activity in MC3T3-E1 cells in a high-glucose environment, promoted the formation of bone mineralized nodules, and upregulated the expression of the osteogenesis-related transcription factors RUNX2, Osterix, and COL1A1-related genes. In addition, MET was able to reduce high glucose-induced reactive oxygen species (ROS) production. In studies on the underlying mechanisms, we found that MET activated the Nrf2/HO-1 signaling pathway and alleviated high-glucose-induced oxidative stress injury. In vivo results showed that MET reduced bone loss and bone microarchitecture destruction in db/db mice. Conclusion: Our results suggest that MET can activate the Nrf2/HO-1 signaling pathway to regulate the inhibition of osteogenic differentiation induced by high glucose thereby protecting T2DOP.
学科与关键词
- Metformin ameliorates calcium oxalate crystallization and stone formation by activating the Nrf2/HO-1 signaling pathway: Two birds with one stoneZhang, Xiaofang; Liang, Futu; Li, Tianyang; Jiang, Yaodong*; Ren, Fei*Archives of Biochemistry and Biophysics, 2023, 739: 109568.被引 1
- Metformin protects retinal pigment epithelium cells against H2O2-induced oxidative stress and inflammation via the Nrf2 signaling cascadeFeng, Qiting; Ruan, Xiangcai; Lu, Min; Bu, Shimiao; Zhang, Yuehong*Graefe's Archive for Clinical and Experimental Ophthalmology, 2023.
- Gegen Qinlian Decoction ameliorates type 2 diabetes osteoporosis via IGFBP3/MAPK/NFATc1 signaling pathway based on cytokine antibody arrayYang, Junzheng; He, Qi; Wang, Yunhan; Pan, Zhaofeng; Zhang, Gangyu; Liang, Jianming; Su, Lijun; Wang, Ailin; Zeng, Chuning; Luo, Haoran; Liu, Lingyun; Li, Jianliang; Rao, Qiuhong; Wang, Baohua*; Wang, Haibin*; Chen, Peng*PHYTOMEDICINE, 2022, 94: 153810.被引 10
